David Schenkein - Sep 8, 2023 Form 3 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/ David P. Schenkein
Stock symbol
REGN
Transactions as of
Sep 8, 2023
Transactions value $
$0
Form type
3
Date filed
9/12/2023, 05:01 PM
Previous filing
Jun 23, 2023
Next filing
Jan 4, 2024

No securities are beneficially owned.